Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells

Cancer Science

Volumn 102, Issue 4, 2011, Pages 756-761

  Ikeda, Osamu ^a   Mizushima, Akihiro ^a   Sekine, Yuichi ^a   Yamamoto, Chikako ^a   Muromoto, Ryuta ^a   Nanbo, Asuka ^a   Oritani, Kenji ^b   Yoshimura, Akihiko ^c   Matsuda, Tadashi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST TUMOR KINASE; PLECKSTRIN; PROTEIN TYROSINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN 2; STAT3 PROTEIN; STAT5 PROTEIN; STAT5B PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; EMBRYO; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOPRECIPITATION; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN-TYROSINE KINASES; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; TYROSINE;

EID: 79952774372     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01842.x     Document Type: Article

References (26)

1. Normanno N, Di Maio M, De Maio E et al. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr Relat Cancer 2005; 12: 721-47.
2. Mitchell PJ, Barker KT, Martindale JE et al. Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumors. Oncogene 1994; 9: 2383-90.
3. Barker KT, Jackson LE, Crompton MR. BRK tyrosine kinase expression in a high proportion of human breast carcinomas. Oncogene 1997; 15: 799-805.
4. Harvey AJ, Crompton MR. Use of RNA interference to validate Brk as a novel therapeutic target in breast cancer: Brk promotes breast carcinoma cell proliferation. Oncogene 2003; 22: 5006-10.
5. Liu L, Gao Y, Qiu H, Miller WT, Poli V, Reich NC. Identification of STAT3 as a specific substrate of breast tumor kinase. Oncogene 2006; 25: 4904-12.
6. Weaver AM, Silva CM. Signal transducer and activator of transcription 5b: a new target of breast tumor kinase/protein tyrosine kinase 6. Breast Cancer Res 2007; 9: R79.
7. Hennighausen L, Robinson GW, Wagner KU, Liu X. Developing a mammary gland is a stat affair. J Mammary Gland Biol Neoplasia 1997; 2: 365-72.
8. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000; 19: 2474-88.
9. Mitchell PJ, Sara EA, Crompton MR. A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Oncogene 2000; 19: 4273-82.
10. Minoguchi M, Minoguchi S, Aki D et al. STAP-2/BKS, an adaptor/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif. J Biol Chem 2003; 278: 11182-9.
11. Ikeda O, Miyasaka Y, Sekine Y et al. STAP-2 is phosphorylated at tyrosine-250 by Brk and modulates Brk-mediated STAT3 activation. Biochem Biophys Res Commun 2009; 384: 71-5.
12. Masuhara M, Nagao K, Nishikawa M, Sasaki M, Yoshimura A, Osawa M. Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains. Biochem Biophys Res Commun 2000; 268: 697-703.
13. Sekine Y, Yamamoto T, Yumioka T et al. Physical and functional interactions between STAP-2/BKS and STAT5. J Biol Chem 2005; 280: 8188-96.
14. Yamamoto T, Yumioka T, Sekine Y et al. Regulation of FcεRI-mediated signaling by an adaptor protein STAP-2/BKS in rat basophilic leukemia RBL-2H3 cells. Biochem Biophys Res Commun 2003; 306: 767-73.
15. Sekine Y, Yumioka T, Yamamoto T et al. Modulation of TLR4 signaling by a novel adaptor protein signal-transducing adaptor protein-2 in macrophages. J Immunol 2006; 176: 380-9.
16. Sekine Y, Tsuji S, Ikeda O et al. STAP-2 regulates integrin-mediated T-cell adhesion through protein degradation of FAK. J Immunol 2007; 179: 2397-407.
17. Ikeda O, Sekine Y, Mizushima A et al. Interactions of STAP-2 with Brk and STAT3 participate in cell growth of human breast cancer cells. J Biol Chem, 2010; 285: 38093-103.
18. Ikeda O, Sekine Y, Yasui T et al. STAP-2 negatively regulates both canonical and non-canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1. Mol Cell Biol 2008; 28: 5027-42.
19. Derry JJ, Richard S, Valderrama Carvajal H et al. Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding ability. Mol Cell Biol 2000; 20: 6114-26.
20. Lukong KE, Huot ME, Richard S. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest. Cell Signal 2009; 21: 1415-22.
21. Grimley PM, Dong F, Rui H. Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev 1999; 10: 131-57.
22. Bromberg J. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development. Breast Cancer Res 2000; 2: 86-90.
23. Sultan AS, Xie J, LeBaron M, Ealley E, Nevalainen MT, Rui H. STAT5 promotes homotypic adhesion and inhibits invasive characteristics of human breast cancer cells. Oncogene 2005; 24: 746-60.
24. Xi S, Zhang Q, Dyer KF et al. Src kinases mediate STAT growth pathways in squamous cell carcinoma of the head and neck. J Biol Chem 2003; 278: 31574-83.
25. Xi S, Zhang Q, Gooding WE, Smithgall TE, Grandis JR. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Cancer Res 2003; 63: 6763-71.
26. Aubele M, Walch AK, Ludyga N et al. Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients. Br J Cancer 2008; 99: 1089-95.